Initial Therapeutics Names Peter DiLaura as CEO
SOUTH SAN FRANCISCO, Calif., April 18, 2024 /PRNewswire/ -- Initial Therapeutics Inc., a life sciences company discovering and developing new small-molecule therapeutics with a novel platform to selectively modulate translation of pathogenic …